Literature DB >> 3137391

The apparent reversal of a wasting syndrome by nutritional intervention in Saguinus mystax.

D Barnard1, J Knapka, D Renquist.   

Abstract

One hundred eighty sexually mature Saguinus mystax were imported from Peru in six lots over a period of 1 year. Within 1 year after arrival, the mortality was 60% and the majority of the tamarins showed signs similar to "wasting marmoset syndrome" (WMS). In an effort to improve the survival rate, an open formula diet replaced the commercial closed formula diet that had been fed since arrival of the tamarins. The open formula diet contained 26.2% crude protein, 12.3% ether extract, 43.3% nitrogen free extract and 5.9% crude fiber on a dry matter basis. The diet was evaluated on the basis of palatability, weight gain, mortality, digestibility, nitrogen balance, serum biochemical parameters and blood counts. The mean daily consumption on an as-is basis was 44.8g or 335 Kcal gross energy/Kg of body wt./day. During the 3 month open formula diet evaluation period average weight increased by 56g (p less than .05), mortality decreased demonstratively, and alopecia and chronic diarrhea were nearly eliminated. Mean daily gross energy intake for S. mystax (335 Kcal/Kg of body wt/day) was substantially greater than previously reported values for callitrichids. WMS signs observed in the S. mystax colony were controlled by providing what appears to be an adequate diet.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137391

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  8 in total

1.  Digestive efficiency mediated by serum calcium predicts bone mineral density in the common marmoset (Callithrix jacchus).

Authors:  Michael R Jarcho; Michael L Power; Donna G Layne-Colon; Suzette D Tardif
Journal:  Am J Primatol       Date:  2012-11-20       Impact factor: 2.371

2.  Tranexamic Acid and Supportive Measures to Treat Wasting Marmoset Syndrome.

Authors:  Takuro Yoshimoto; Kimie Niimi; Eiki Takahashi
Journal:  Comp Med       Date:  2016-12-01       Impact factor: 0.982

3.  Pathology of captive moustached tamarins (Saguinus mystax).

Authors:  Alfonso S Gozalo; Lily I Cheng; Marisa E St Claire; Jerrold M Ward; William R Elkins
Journal:  Comp Med       Date:  2008-04       Impact factor: 0.982

4.  Current practices in nutrition management and disease incidence of common marmosets (Callithrix jacchus).

Authors:  Anna Goodroe; Lynn Wachtman; William Benedict; Krystal Allen-Worthington; Jaco Bakker; Monika Burns; Leslie Lynn Diaz; Edward Dick; Mary Dickerson; Steven J Eliades; Olga Gonzalez; Dina-Jo Graf; Keren Haroush; Takashi Inoue; Jessica Izzi; Allison Laudano; Donna Layne-Colon; Mathias Leblanc; Brian Ludwig; Andres Mejia; Cory Miller; Anna Sarfaty; Megan Sosa; Eric Vallender; Celeste Brown; Larry Forney; Nancy Schultz-Darken; Ricki Colman; Michael Power; Saverio Capuano; Corinna Ross; Suzette Tardif
Journal:  J Med Primatol       Date:  2021-04-28       Impact factor: 0.821

Review 5.  Clinical Management of Gastrointestinal Disease in the Common Marmoset (Callithrix jacchus).

Authors:  Casey Fitz; Anna Goodroe; Lauren Wierenga; Andres Mejia; Heather Simmons
Journal:  ILAR J       Date:  2020-12-31       Impact factor: 1.521

6.  The use of glucocorticoids in marmoset wasting syndrome.

Authors:  Pete Otovic; Shanequa Smith; Eric Hutchinson
Journal:  J Med Primatol       Date:  2015-01-23       Impact factor: 0.667

Review 7.  Nutritional and ecological perspectives of the interrelationships between diet and the gut microbiome in multiple sclerosis: Insights from marmosets.

Authors:  Maria Elisa Perez-Muñoz; Scott Sugden; Hermie J M Harmsen; Bert A 't Hart; Jon D Laman; Jens Walter
Journal:  iScience       Date:  2021-06-10

8.  Serum albumin and body weight as biomarkers for the antemortem identification of bone and gastrointestinal disease in the common marmoset.

Authors:  Victoria K Baxter; Gillian C Shaw; Nathaniel P Sotuyo; Cathy S Carlson; Erik J Olson; M Christine Zink; Joseph L Mankowski; Robert J Adams; Eric K Hutchinson; Kelly A Metcalf Pate
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.